Login | Register

Study Evidence Supports New Drug to Prevent Blood Clotting

The drug Eliquis (apixaban) is a new anticoagulant option that is at least as effective as other current blood thinners and possibly better at reducing rates of major bleeding, according to a recent trial. Eliquis, an oral direct Factor Xa inhibitor developed by Bristol-Myers Squibb (NYSE: BMY) and Pfizer Inc. (NYSE: PFE), was recently used in a six-month AMPLIFY trial...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *